Josh Hardman
Advisor @2a Biosciences
Signup · Get unlimited contacts
WORK HISTORY
Advisor @2a Biosciences
EDUCATION
The London School of Economics and Political Science (LSE)
BSc Government
University of California, Berkeley
Education Abroad Program
SKILLS
ABOUT JOSH HARDMAN
Josh Hardman is the Founder & Editor of Psychedelic Alpha, an independent platform covering psychedelic drug development, regulation, and access.Psychedelic Alpha tracks:• The psychedelic drug development pipeline• Regulatory and policy developments in the U.S. and internationally• Funding, investment, and commercialisation dynamics• Real-world rollout considerations• Research trends and deep dives• Intellectual property• Non-traditional access pathwaysThe platform is read by biotech and pharma executives, investors and philanthropists, policymakers and advocates, clinicians and practitioners, and researchers and scientists seeking sober, data-driven coverage of the sector. Its insights and data have been featured outlets like CNN, the New York Times, and the BBC; as well as publications from the UN, EUDA, RAND, VA, and UK Parliament.Beyond publishing, Hardman advises various organisations through Psychedelic Alpha\'s consultancy and advisory arm.Hardman has also been an invited Expert to bodies including the U.S. Department of Health and Human Services and UK Parliament, as well as a guest lecturer at institutions including UW-Madison (Wisconsin) and Monash University (Melbourne). He has also appeared on podcasts, radio, and other media engagements.Subscribe, explore exclusive trackers, or discuss advisory opportunities at psychedelicalpha.com.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.